CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Novartis to pay $1.1B upfront for UK biotech Myricx to expand the pharma's ADC pipeline","$":{"href":"/biotech/novartis-pay-11b-upfront-myricx-expand-adc-pipeline","hreflang":"en"}}]}

Positive
AI Analysis

Summary

Novartis is acquiring UK biotech Myricx Bio for $1.1 billion upfront to expand its antibody-drug conjugate (ADC) pipeline with a novel payload platform.

Importance:7/10
Sentiment:
0.60
acquisitionADCantibody-drug conjugatepipeline expansion
Related Companies

Read the original article

Published by FierceBiotech on July 6, 2026 4:22 AM

Read Original